GSP Crop Science IPO: Agrochemical Manufacturer Expanding Product Portfolio – Should You Subscribe?

Gyanesh DSIJ / 14 Mar 2026 / Categories: IPO Analysis, Trending

GSP Crop Science IPO: Agrochemical Manufacturer Expanding Product Portfolio – Should You Subscribe?

Price band is Rs 304 to Rs 320. IPO consists of a Fresh Issue and Offer for Sale aggregating up to 1,25,000 equity shares of face value ₹10 each. Listing proposed on NSE and BSE.

GSP Crop Science Limited – IPO Note

IPO Snapshot (At-a-Glance)

Item

Details

Issue Type

Fresh Issue + Offer for Sale

Issue Size

Fresh Issue up to ₹240 crore; OFS up to 5,000,000 equity shares

Total Offer Size

Up to 1,25,000 Equity Shares (aggregating up to Rs 400 crore)

Face Value

₹10 per share

Price Band

Rs 304 to Rs 320

Lot Size

46 shares

Minimum Investment (Retail)

Rs 14,720

Issue Opens

March 16, 2026

Issue Closes

March 18, 2026

Listing

NSE, BSE

Promoters / Selling Shareholders

Vilasben Vrajmohan Shah, Bhavesh Vrajmohan Shah, Kappa Trust

 

Company Overview & Business Operations

GSP Crop Science Limited is a research-driven agrochemical company engaged in the development and manufacturing of insecticides, herbicides, fungicides, and plant growth regulators in India.

The company operates across two key business segments – Technicals and Formulations, enabling it to participate across different stages of the agrochemical value chain. Its product portfolio includes a wide range of crop protection and plant health products used by agricultural producers.

GSP Crop Science has developed a diversified product portfolio supported by in-house research and development capabilities, allowing the company to develop new agrochemical formulations and expand product registrations. As of September 30, 2025, the company had 524 product registrations across insecticides, herbicides, fungicides, and plant growth regulators spanning both its formulations and technical businesses.

Through its product development capabilities and broad portfolio, the company aims to provide crop protection solutions across multiple agricultural applications.


Product Portfolio

The company manufactures a diversified portfolio of agrochemical products catering to crop protection and plant health needs across agriculture.

Insecticides – Products designed to protect crops from insect attacks and pest infestations.

Herbicides – Agrochemical solutions used for weed management and crop protection during various stages of cultivation.

Fungicides – Products formulated to prevent or control fungal diseases that can damage crops and reduce yields.

Plant Growth Regulators (PGRs) – Chemical substances that influence plant growth processes such as flowering, fruiting, and yield optimization.

The company’s product mix across formulations and technicals allows it to address multiple agricultural requirements and cater to diverse crop segments.


Industry Outlook

The agrochemical industry continues to benefit from structural demand drivers linked to agricultural productivity and global food security. Rising demand for higher agricultural output is increasing the need for effective crop protection solutions, while the adoption of advanced agrochemical formulations is helping improve crop yields and disease resistance. The crop protection market is also expanding due to growing global food demand and the gradual decline in arable land availability, which necessitates more efficient farming practices. In addition, companies across the sector are placing greater emphasis on research and development to introduce new molecules and secure product registrations.

Within this landscape, India has emerged as a key agrochemical manufacturing hub, supported by its strong chemical manufacturing ecosystem, cost advantages, and expanding export capabilities. Companies with diversified product portfolios and strong R&D capabilities are well positioned to benefit from these long-term industry trends.

 

Objects of the Issue

The company proposes to utilise the Net Proceeds from the Fresh Issue towards the following objects:

₹170 crore will be used for repayment or prepayment of certain outstanding borrowings of the company.

The remaining proceeds will be utilised towards general corporate purposes.

(Proceeds from the Offer for Sale will be received by the selling shareholders and will not accrue to the company.)

 

Financial Performance

(₹ in crore – Restated Financial Statements)

Period Ended

Sep 30, 2025

FY25

FY24

FY23

Revenue from Operations

844.2

1,287.3

1,152.1

1,203.3

Profit After Tax

81.0

81.4

55.5

17.5

EBITDA

138.8

164.0

130.4

81.2

EPS (₹)

21.22*

21.20

13.49

4.20

Return on Net Worth

15.62%*

18.38%

15.00%

4.79%

Net Asset Value / Share (₹)

135.80

115.34

94.94

88.18

*Not annualised.

The company has demonstrated strong profitability improvement over the past three years, with PAT rising from ₹17.5 crore in FY23 to ₹81.4 crore in FY25, supported by expansion in revenue and operating margins.

 

Peer Comparison

Company Name

Revenue (₹ crore)

EPS (₹)

P/E (x)

RoNW (%)

 

GSP Crop Science

1,287.3

21.20

18.1 (Post
issue)

18.38

 

PI Industries

7,977.8

109.44

28.25

16.35

 

Sumitomo Chemical India

3,148.5

10.13

39.23

17.42

 

Dhanuka Agritech

2,035.1

65.55

15.13

21.18

 

Rallis India

2,662.9

6.43

40.12

6.61

 

Bharat Rasayan

1,173.0

339.14

4.14

12.47

 

India Pesticides

828.6

7.14

21.57

9.15

 

Excel Industries

978.0

67.87

13.13

5.37

 

 

Strengths

Diversified agrochemical product portfolio
The company offers a broad range of insecticides, herbicides, fungicides and plant growth regulators catering to crop protection needs.

Research-driven product development capabilities
Strong focus on research and development enables the company to introduce new formulations and expand registrations.

Large number of product registrations
As of September 30, 2025, the company had 524 registrations across its formulations and technicals segments.

Presence across technicals and formulations businesses
Participation across multiple stages of the agrochemical value chain provides diversification in product offerings.

Improving operating profitability
EBITDA margins expanded from 6.75% in FY23 to 12.74% in FY25, reflecting operating leverage and improved product mix.


Key Risks

Dependence on regulatory approvals and product registrations
The agrochemical industry is highly regulated, and delays in approvals may impact product launches and growth.

Volatility in agricultural demand
Demand for crop protection products is linked to agricultural cycles, weather conditions, and crop patterns.

Execution risks in product development and commercialization
Failure to successfully develop or commercialize new agrochemical products could affect growth prospects.

Utilisation of IPO proceeds subject to management discretion
The company will have flexibility in deploying part of the proceeds for general corporate purposes.

Promoter shareholding concentration
Promoters hold approximately 90.55% of the pre-offer shareholding, which may allow them to exert significant influence over corporate decisions.

 

Outlook & Valuation

Apply. GSP Crop Science operates in the agrochemical sector, which benefits from structural demand drivers such as rising food consumption, increasing focus on crop protection, and the need to improve agricultural productivity. The company reported FY25 revenue of ₹1,287.3 crore with a Return on Net Worth of 18.38%, indicating healthy profitability and efficient capital utilization.

At the upper price band of ₹320, the IPO is valued at around 18.1x FY25 earnings on a fully diluted post-issue basis. Compared with listed peers, the valuation appears reasonable. Larger companies such as PI Industries and Sumitomo Chemical India trade at higher multiples of around 28x–39x, while companies like Dhanuka Agritech and Excel Industries trade at relatively moderate valuations.

The company’s RoNW is competitive within the sector and compares favorably with peers such as Rallis India and India Pesticides. However, investors should note that the agrochemical industry is exposed to factors such as weather conditions, agricultural cycles, and regulatory approvals.

Overall, considering the reasonable valuation and healthy return profile, the IPO appears fairly priced and may be considered by investors with a medium- to long-term investment horizon.